The healthcare landscape is witnessing a development with the emergence of GLP-1 delivery devices. These cutting-edge formulations offer a possible method to delivering glucagon-like peptide-1 therapies for individuals living with the disease . Instead of needles, a simple patch applied to the skin could provide a steady amount of the treatment , p